Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

T-686 inhibits thrombus formation without hemostatic impairment

Sep. 5, 1997

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

DuPont Merck discloses new anticoagulants

Sep. 4, 1997

Reteplase is superior to alteplase in pulmonary embolism

Sep. 2, 1997

New inhibitors of platelet aggregation from Taiwan

Sep. 2, 1997

Spotlight on fibrinogen antagonists

Sep. 2, 1997

TNK-tPA as effective as tPA, studies show

Aug. 27, 1997

PRISM-PLUS results on tirofiban released

Aug. 27, 1997

Initial PURSUIT trial results presented in Stockholm

Aug. 25, 1997

Lovenox superiority established in ESSENCE trial

Aug. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...